Del Nido Cardioplegia: Elixir of Choice for Pediatric Myocardial Protection.
نویسنده
چکیده
I think we’re going to be really talking about Del Nido today, because of its observed effectiveness. It kind of went viral. A lot of surgeons wound up leaving Boston and going through other centers and taking it with them and it sort of spread like a little virus and other surgeons wanted this single-dose cardioplegia. The idea of operating uninterrupted sounds pretty appealing. Like Bob (Groom) mentioned—let’s see here, if I could—yeah, I’m going to just go out here. I’ve been using this—well, we’ve (Children’s Health Dallas) been using this solution, excuse me, at our institution for about 10 years on over 3700 congenital surgeries. You know, we do pediatric and adult congenital procedures and we use a solution for everything. We were recently assigned three stars in the Society of Thoracic Surgeons (STS) based on the mortality risk models. Only 6 of 116 centers were assigned that rating and though I don’t think cardioplegia is the reason you get a high rating, I think to get really good results you do need to protect the myocardium. And when I asked around on the six centers and they were well represented on microplegia, custodial, Del Nido. It was across the board, so there was no inconsistency there. We’ve been using this solution for so long and presenting it at these meetings, we constantly get asked what’s your protocol, what’s your cardioplegic circuit, because we have this mini (cardioplegia) circuit. If you were at the myocardial workshop you got to see that, and we recently published our experience with the solution a couple of years back in JECT. I’m going to start off with just a real quick overview in just pediatric myocardial protection, and then we’ll get into the Del Nido part of the talk. First, I think most of you know that cardioplegia is just a part of myocardial protection. When we most often talk about myocardial protection we talk about cardioplegia, but myocardial protection is really anything that reduces metabolic demands in activity. Cardioplegia prolongs the tolerance to ischemia. Excuse me. I’m doing two things at once here and I’m not doing a good job of that. All right. When you look at all of these techniques that everyone uses, it’s kind of crazy. They’re all across the board. There’s really no consistency and it’s really a mess. There’s a lot of conflicting techniques and some are actually literally the opposite of each other. I know I remember being a student and going on clinical rotations and we had surgeons going cold, continuous, and warm. It really was like working with a bunch of bartenders with their own little cocktail. If you really think about it, cardioplegia actually is quite literally almost a cocktail. Maybe your surgeons like a Sazerac style cardioplegia, but you know, we used to do beer and alcohol during these sessions in here a long time ago. I don’t know why they stopped doing that, but alcohol was a very important part of these talks. Let’s see here: to even complicate it even further is now you have these differences of the immature heart. As the myocardium develops the myocites and myofibrils elongate, the number of mitochondria increases, and it’s responsible for adenosine triphosphate (ATP), of course, and also, the structure and amount of sarcoplasmic reticulum change, which, you know, is responsible for calcium management. For the physiologic differences, basically, it can be broken down into how the myocardium manages a calcium energy consuming processes, and we’ll keep this in mind later in the presentation when we talk about the different formulations. If you could actually address these differences in the anatomy and physiology, it would be a great way to create a very special, specific cardioplegia for a very specific subgroup of patients. But, unfortunately, it’s actually unclear when the transition happens from immature to mature. You don’t really know, so to actually tailor a cardioplegia for a pediatric patient is actually Address correspondence to: Richard M. Ginther, Jr., CCP, FPP, UT Southwestern Medical Center, Children's Health Dallas, 1935 Medical District Drive, Dallas, TX 75235. E-mail: [email protected]
منابع مشابه
Use of del Nido Cardioplegia for Adult Cardiac Surgery at the Cleveland Clinic: Perfusion Implications.
Cardiac arrest by cardioplegia provides a reproducible and safe method to induce and maintain electromechanical cardiac quiescence. Techniques of intraoperative myocardial protection are constantly evolving. For the past three decades, modified Buckberg cardioplegia solution has been used for adult cardiac surgery at the Cleveland Clinic. This formulation serves as the crystalloid component, wh...
متن کاملUse of del Nido cardioplegia solution and a low-prime recirculating cardioplegia circuit in pediatrics.
The evolution of myocardial protection techniques has been both the source of milestone advancements and controversial debate in cardiac surgery. Our institution has modified a low-prime cardioplegia system (CPS) and adopted a single-dose cardioplegia solution (del Nido cardioplegia) for our congenital heart disease population. The goal of this article is to describe our CPS and outline our myo...
متن کاملHistory and use of del Nido cardioplegia solution at Boston Children's Hospital.
Cardioplegia is an integral and essential method of myocardial protection for patients of all ages requiring cardiac surgery in which the heart must be stopped. Numerous cardioplegia solutions and delivery methods have been developed. The del Nido cardioplegia solution has been in use for 18 years at Boston Children's Hospital. This is a unique four parts crystalloid to one part whole blood for...
متن کاملdel Nido versus St. Thomas Cardioplegia Solutions: A Single-Center Retrospective Analysis of Post Cross-Clamp Defibrillation Rates.
There are many cardioplegia solutions currently in use for pediatric cardiopulmonary bypass (CPB). The most common being del Nido solution. Another common cardioplegia solution used for pediatric CPB is St. Thomas. In October 2014, Children's Mercy Kansas City changed from the use of modified St. Thomas to del Nido. This study compared rates of post cross-clamp fibrillation requiring defibrilla...
متن کاملDel Nido Cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: a propensity matched comparison
OBJECTIVE Del Nido (DN) cardioplegia solution provides a depolarized hyperkalemic arrest lasting up to 60 minutes, and the addition of lidocaine may limit intracellular calcium influx. Single-dose DN cardioplegia solution may offer an alternative myocardial protection strategy to multi-dose cold whole blood (WB) cardioplegia following acute myocardial infarction (AMI). METHODS We retrospectiv...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- The journal of extra-corporeal technology
دوره 48 2 شماره
صفحات -
تاریخ انتشار 2016